pyrroles has been researched along with aldosterone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Fraser, R; Kenyon, CJ; Shepherd, RM | 1 |
| Grose, JH; Lacourcière, Y; Lebel, M | 1 |
| Bock, KD; Hocevar, V; Merguet, P; Rausch-Stroomann, JG; Schley, G; Schröder, E; Schümann, HJ | 1 |
| Blei, AT; Blendis, LM; Thuluvath, PJ; Wong, F | 1 |
| AGARWAL, KN; GARBY, L | 1 |
| AGARWAL, KN; HJERTEN, S | 1 |
| Bech, JN; Holst, LM; Paulsen, L; Pedersen, EB; Starklint, J | 1 |
| Funder, JW | 1 |
| Kino, T; Matsuzawa, Y; Nishikawa, T; Omura, M; Saito, J; Suematsu, S | 1 |
| Benecke, A; Boulkroun, S; Eilebrecht, S; Golib Dzib, JF; Hütt, MT; Lesne, A; Sonnenschein, N; Zennaro, MC | 1 |
| Allolio, B; Bidlingmaier, M; Blouin, K; Drechsler, C; Fassnacht, M; Hammer, F; Krane, V; März, W; Pilz, S; Ritz, E; Schönfeld, S; Tomaschitz, A; Wanner, C | 1 |
| Cui, W; Hu, HJ; Liu, DM; Liu, J; Wang, Q; Zhang, HL; Zhang, YN | 1 |
| Aoki, K; Arai, K; Homma, T; Ishikawa, H; Mizuno, M; Morikawa, Y; Sada, T; Tsuruoka, H; Ubukata, N | 1 |
| Adler, GK; Baudrand, R; Brooks, D; Garza, AE; Katayama Rangel, IA; Moize, B; Pojoga, LH; Ranjit, S; Romero, JR; Treesaranuwattana, T; Trefts, E; Williams, GH; Yao, TM | 1 |
| Bavuu, O; Fukuda, D; Ganbaatar, B; Ise, T; Kusunose, K; Matsuura, T; Sata, M; Soeki, T; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
| Chang, Y; Gao, X; Han, Y; Hao, J; Liang, L; Qiang, P; Shimosawa, T; Xian, Y; Xiong, Y; Xu, Q; Yang, F | 1 |
1 review(s) available for pyrroles and aldosterone
| Article | Year |
|---|---|
Aldosterone, hypertension and heart failure: insights from clinical trials.
Topics: Aldosterone; Animals; Anticholesteremic Agents; Atorvastatin; Clinical Trials as Topic; Dihydrotestosterone; Drug Therapy, Combination; Enzyme Inhibitors; Female; Heart Failure; Heptanoic Acids; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Mice; Mineralocorticoid Receptor Antagonists; Ouabain; Pyrroles; Quinolines; Rats; Spironolactone | 2010 |
2 trial(s) available for pyrroles and aldosterone
| Article | Year |
|---|---|
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female; Heart Failure; Hemodynamics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Pyrroles; Renin; Sodium; Thirst; Treatment Outcome; Water-Electrolyte Balance | 2003 |
Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Kidney Function Tests; Lithium; Male; Natriuretic Peptide, Brain; Pyrroles; Renin; Sodium; Vasopressins | 2009 |
13 other study(ies) available for pyrroles and aldosterone
| Article | Year |
|---|---|
Membrane permeability to K+ and the control of aldosterone synthesis: effects of valinomycin and cromakalim in bovine adrenocortical cells.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Benzopyrans; Cattle; Cell Membrane Permeability; Cromakalim; In Vitro Techniques; Ion Transport; Potassium; Pyrroles; Steroid 21-Hydroxylase; Valinomycin | 1992 |
Short-term monotherapy with the potassium channel activator BRL 34915 on endocrine sodium regulation in essential hypertension.
Topics: Administration, Oral; Adult; Aldosterone; Atrial Natriuretic Factor; Benzopyrans; Blood Pressure; Cromakalim; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pyrroles; Renin; Renin-Angiotensin System; Sodium | 1989 |
[Hypertension and tachycardia in acute intermittent porphyria].
Topics: Adult; Aldosterone; Amino Acids; Anemia; Blood Pressure; Catecholamines; Depression, Chemical; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Kidney Function Tests; Levulinic Acids; Middle Aged; Porphyrias; Porphyrins; Propranolol; Pyrroles; Renin; Sympatholytics; Tachycardia; Vanilmandelic Acid | 1970 |
INHIBITION BY CORTICOSTEROIDS OF RED CELLS LYSIS IN VITRO.
Topics: Adrenal Cortex Hormones; Aldosterone; Benzoates; Chloromercuribenzoates; Dexamethasone; Erythrocytes; Glucocorticoids; Hemolysis; Hydrocortisone; In Vitro Techniques; Pharmacology; Prednisolone; Pregnadienes; Pyrroles; Research; Rh-Hr Blood-Group System | 1964 |
AN ELECTROPHORETIC STUDY OF HUMAN ERYTHROCYTES, INCUBATED WITH CORTICOSTEROIDS AND SULFHYDRYL REACTION SUBSTANCES.
Topics: Adrenal Cortex Hormones; Aldosterone; Electrophoresis; Erythrocytes; Glucocorticoids; Hemolysis; Pharmacology; Prednisolone; Pregnadienes; Pyrroles; Research | 1964 |
Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells.
Topics: Aldosterone; Angiotensin II; Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 CYP11B2; Diabetic Nephropathies; Glucose; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Mesangial Cells; Pyrroles; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
A network perspective on metabolic inconsistency.
Topics: Adenoma; Adipates; Adrenal Glands; Aldosterone; Humans; Metabolic Networks and Pathways; Proline; Pyrroles; Systems Biology; Transcriptome | 2012 |
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Anticholesteremic Agents; Atorvastatin; Death, Sudden, Cardiac; Drug Synergism; Female; Heptanoic Acids; Humans; Hydrocortisone; Kaplan-Meier Estimate; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Young Adult | 2013 |
Atorvastatin suppresses aldosterone-induced neonatal rat cardiac fibroblast proliferation by inhibiting ERK1/2 in the genomic pathway.
Topics: Aldosterone; Animals; Atorvastatin; Blotting, Western; Cell Cycle; Cell Proliferation; Cells, Cultured; Chronic Disease; DNA; Fibroblasts; Flow Cytometry; Heart Failure; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Mineralocorticoid Receptor Antagonists; Myocardium; Pyrroles; Rats; Rats, Sprague-Dawley | 2013 |
Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Topics: Administration, Oral; Adrenalectomy; Aldosterone; Animals; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Dose-Response Relationship, Drug; Eplerenone; Female; HEK293 Cells; Humans; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Potassium; Protein Binding; Pyrroles; Rabbits; Radioligand Assay; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Sodium; Spironolactone; Sulfones; Transcriptional Activation; Transfection; Urological Agents; Water-Electrolyte Balance | 2015 |
Striatin heterozygous mice are more sensitive to aldosterone-induced injury.
Topics: Aldosterone; Animals; Blood Pressure; Calmodulin-Binding Proteins; Eplerenone; Kidney; Male; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Pyrroles; Spironolactone; Sulfones | 2020 |
Esaxerenone, a selective mineralocorticoid receptor blocker, improves insulin sensitivity in mice consuming high-fat diet.
Topics: 3T3-L1 Cells; Adiponectin; Aldosterone; Animals; Diet, High-Fat; Insulin; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Pyrroles; Receptors, Mineralocorticoid; Sulfones; Transaminases | 2022 |
Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone.
Topics: Aldosterone; Animals; Eplerenone; Fibrosis; Macrophages; Mice; Myofibroblasts; Pyrroles; Rats; Receptors, Mineralocorticoid; Renal Insufficiency, Chronic; Sulfones; Transforming Growth Factor beta1 | 2022 |